GlaxoSmithKline sues Pfizer over meningitis vaccine patent

This report is a localnews.ie summary based on public court reporting and records; sources are listed below.

GlaxoSmithKline Biologicals SA sued Pfizer Ireland Pharmaceuticals and Pfizer over alleged meningitis vaccine patent infringement in the Commercial Court in Dublin, reported on 8 November 2016. The dispute concerned Trumenba, a product used to prevent a form of bacterial meningitis, which GSK claimed breached four patents. The company sought an injunction, orders concerning allegedly infringing products, disclosure of supply information and damages. Mr Justice Brian Cregan admitted the action to the Commercial Court after being told both sides consented to the transfer.